Brief: Percheron Therapeutics Says James Garner To Step Down As CEO And Managing Director
10/08/2026 02:41
BRIEF-Percheron Therapeutics Says James Garner To Step Down As CEO And Managing Director Aug 10 (Reuters) - Percheron Therapeutics Ltd PER.AX:
JAMES GARNER TO STEP DOWN AS CEO AND MANAGING DIRECTOR
APPOINTS MICHAEL BAKER AS CEO AND MANAGING DIRECTOR EFFECTIVE 5 OCTOBER 2026
Further company coverage: PER.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Percheron Therapeutics
See all newsBrief: Invion Announces Preclinical Research Collaboration With Percheron Therapeutics
Brief: Percheron Therapeutics Receives Firm Commitments For A$2.3 Million Institutional Placement
Brief: Percheron Therapeutics Appoints Ambrosini as Interim Board Member During CEO Transition Period
Brief: Percheron Therapeutics Says Vanderbilt Health To Conduct Clinical Trial Of Hmbd-002 In Acute Myeloid Leukaemia
Brief: Percheron Therapeutics Says James Garner To Step Down As CEO And Managing Director